Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation
Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation
复制标题
DOI:
10.1161/01.atv.0000215638.53414.99
复制
发表时间:
2006-05-01
影响因子:
8.7
通讯作者:
Jain, MK
中科院分区:
文献类型:
--
作者:
Lin, ZY;Hamik, A;Jain, MK
Objective - The serine protease thrombin can dramatically alter endothelial gene expression in a manner that confers a proinflammatory phenotype. Recent studies have identified the Kruppel-like factor 2 (KLF2) as a critical regulator of endothelial gene expression. Herein, we provide evidence that KLF2 inhibits thrombin-mediated endothelial activation via alterations in expression of its principal receptor protease-activated receptor-1 (PAR-1).Methods and Results - Forced expression of KLF2 in human umbilical vein endothelial cells potently inhibited the ability of thrombin to induce multiple prothrombotic factors ( tissue factor, CD40L, plasminogen activator inhibitor-1), cytokines/chemokines (eg, monocyte chemotactic protein-1, interleukin-6 [IL-6], IL-8), and matrix degrading enzymes ( eg, matrix metalloproteinases 1, 2, and 9). Mechanistically, KLF2 inhibits PAR-1 expression and, as a consequence, thrombin-mediated nuclear factor kappa B ( NF-kappa B) nuclear accumulation and DNA binding. Conversely, small interfering RNA - mediated knockdown of KLF2 increases PAR-1 expression and thrombin-mediated induction of NF-kappa B activation.Conclusion - These studies identify KLF2 as a novel regulator of PAR-1 expression and thrombin action in endothelial cells.